MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-11-2026
Country |
 USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
382 M |
Market Cap[1] |
$ 126 B |
EBITDA (LTM) |
$ 5.7 B |
P/E (LTM) |
38.83 |
P/S (LTM) |
5.36 |
EPS (LTM) |
8.46 |
Stryker Corporation is an international company specializing in the production of medical equipment and instruments for surgery. The company was founded in 1941 in the United States and has since become one of the leaders in its field.
Stryker Corporation offers a wide range of products, including implants for orthopedics, neurosurgery, traumatology, and other areas of medicine, as well as tools for surgical operations and rehabilitation equipment.
The company is actively developing and expanding its business around the world. Today, SYK has offices in more than 100 countries and holds leading positions in the medical equipment market.
One of the company's main goals is to create innovative products that will help improve the quality of life for patients and facilitate the work of medical professionals. Stryker Corporation also actively works on improving its technologies and processes to ensure high-quality products and maximum safety for patients.
Stryker Corporation is an example of a successful business that combines innovation, quality, and responsibility to patients.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
$ 11.75 | -3.29 % | $ 1.76 B | Nasdaq Global Select Market | USA |
 |
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | USA |
 |
Delcath Systems
DCTH
|
$ 8.98 | -1.32 % | $ 322 M | Nasdaq Capital Market | USA |
 |
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market |  China |
 |
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | USA |
 |
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | USA |
 |
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | USA |
 |
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | USA |
 |
FONAR Corporation
FONR
|
$ 18.41 | 0.38 % | $ 121 M | Nasdaq Capital Market | USA |
 |
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | USA |
 |
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | USA |
 |
Inogen
INGN
|
$ 6.32 | -2.02 % | $ 168 M | Nasdaq Global Select Market,SPB | USA |
 |
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | USA |
 |
IRIDEX Corporation
IRIX
|
$ 1.35 | - | $ 21.8 M | Nasdaq Global Select Market | USA |
 |
IRadimed Corporation
IRMD
|
$ 100.97 | 1.78 % | $ 1.28 B | Nasdaq Global Select Market | USA |
 |
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | USA |
 |
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | USA |
 |
LivaNova PLC
LIVN
|
$ 62.4 | -1.33 % | $ 3.4 B | Nasdaq Global Select Market |  Britain |
 |
LENSAR
LNSR
|
$ 5.56 | -8.4 % | $ 64 M | Nasdaq Capital Market | USA |
 |
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | USA |
 |
AxoGen
AXGN
|
$ 32.61 | 2.71 % | $ 1.5 B | Nasdaq Capital Market,SPB | USA |
 |
CONMED Corporation
CNMD
|
$ 36.56 | -0.19 % | $ 1.13 B | NYSE,SPB | USA |
 |
Medtronic PLC
MDT
|
$ 86.58 | -0.68 % | $ 111 B | NYSE,SPB | USA |
 |
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | USA |
 |
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market |  Israel |
 |
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | USA |
 |
Electromed
ELMD
|
$ 24.7 | 0.86 % | $ 209 M | NYSE American | USA |
 |
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | USA |
 |
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market |  Canada |
 |
InspireMD
NSPR
|
$ 1.79 | 3.47 % | $ 115 M | NYSE American | Israel |
 |
Orthofix Medical
OFIX
|
$ 11.72 | -1.26 % | $ 464 M | Nasdaq Global Select Market,SPB |  Curacao |
 |
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | USA |
 |
Cytosorbents Corporation
CTSO
|
$ 0.7 | 3.3 % | $ 38.1 M | Nasdaq Capital Market | USA |
 |
Aethlon Medical
AEMD
|
$ 2.16 | -6.09 % | $ 3.37 M | Nasdaq Capital Market | USA |
 |
Profound Medical Corp.
PROF
|
$ 5.15 | -4.63 % | $ 180 M | Nasdaq Global Select Market | Canada |
 |
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | USA |
 |
Penumbra
PEN
|
$ 334.17 | -0.41 % | $ 13 B | NYSE,SPB | USA |
 |
AdaptHealth Corp.
AHCO
|
$ 11.48 | 10.7 % | $ 1.55 B | Nasdaq Capital Market | USA |
 |
Myomo
MYO
|
$ 0.7 | -1.83 % | $ 29.3 M | NYSE American | USA |
 |
Insulet Corporation
PODD
|
$ 225.5 | -0.7 % | $ 15.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
$ 2.4 | -1.64 % | $ 141 M | Nasdaq Global Select Market | Israel |
 |
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | USA |
 |
EDAP TMS S.A.
EDAP
|
$ 3.91 | 4.83 % | $ 146 M | Nasdaq Global Market |  France |
 |
Quanterix Corporation
QTRX
|
$ 3.82 | -3.05 % | $ 163 M | Nasdaq Global Select Market,SPB | USA |
 |
OrthoPediatrics Corp.
KIDS
|
$ 15.91 | -3.4 % | $ 373 M | Nasdaq Global Select Market,SPB | USA |
 |
Outset Medical
OM
|
$ 3.53 | -2.35 % | $ 53.7 K | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.